Lidocaine-Prilocaine Cream Recalled Due to Incomplete Stability Studies
Akorn, Inc. is recalling all lots of Lidocaine 2.5% & Prilocaine 2.5% Cream due to CGMP deviations. The manufacturer went out of business and could not complete required stability studies to verify product integrity.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall due to CGMP deviations with no reported illnesses or injuries. The recall is driven by the firm's inability to complete stability studies, making it a precautionary, compliance-driven action rather than a response to documented harm.
Plain-English summary
Akorn, Inc. is recalling all lots of Lidocaine 2.5% & Prilocaine 2.5% Cream due to Current Good Manufacturing Practice (CGMP) deviations. The manufacturer went out of business and was unable to continue the stability studies required to verify that the product maintains its safety and effectiveness throughout its shelf life.
The affected product is a prescription cream available in 30-gram tubes, manufactured by HI-TECH PHARMACAL CO., INC. (Amityville, NY). All lot numbers were distributed nationwide in the USA and Puerto Rico.
Patients and healthcare providers should not use the recalled product. Anyone currently taking this medication should consult their healthcare provider or pharmacist about alternative treatment options.
The recalled product
- Product
- Lidocaine 2.5% & Prilocaine 2.5% Cream, 30 gram tubes, Rx Only, Manufactured by: HI-TECH PHARMACAL CO., INC., Amityville, NY 11701. ALL NDCs
- Manufacturer
- Akorn, Inc.
- Category
- Drug — Topical Anesthetic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Part of a larger recall action
This product is one of 86 recalled by Akorn, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 86 products in this recall →Related recalls
Same manufacturer · Akorn, Inc.
See all →- HighTobramycin Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighGuaifenesin Oral Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Calcitriol Injection Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-06-07
- HighAkorn Hydromorphone Hydrochloride Injection Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
- HighMidazolam Injection Recalled Due to Manufacturing Compliance and Stability Study Issues
FDA (Drugs) · 2023-06-07
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- SevereAkorn Recalls Lidocaine and Prilocaine Cream Due to Impurity
FDA (Drugs) · 2018-08-15
- HighFDA Recalls Lidocaine Prilocaine Cream Due to Manufacturing Compliance Issue
FDA (Drugs) · 2022-05-11
- ModerateLidocaine Oral Topical Solution Recalled Due to Failed Viscosity Specification
FDA (Drugs) · 2022-05-11
- ModerateLidocaine Cream 4% Recalled Due to Manufacturing Quality Deviations
FDA (Drugs) · 2022-03-30
- ModerateLidocaine Cream 4% Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- HighLidocaine Hydrochloride Jelly Recalled Due to cGMP Deviations and Turbidity
FDA (Drugs) · 2022-09-14